PT Metro Healthcare Indonesia Tbk (ISX:CARE) Long-Term Debt: Rp525,985 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:CARE PT Metro Healthcare Indonesia Tbk ISX:CARE
76 GF Score
Price Rp418.00
GF Value Rp370.15
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is PT Metro Healthcare Indonesia Tbk Long-Term Debt?

PT Metro Healthcare Indonesia Tbk ISX:CARE -0.95% 76 Long-Term Debt is Rp525,985 Mil as of Mar. 2026. GuruFocus rates ISX:CARE with a GF Score™ of 76/100 and a GF Value™ of Rp370.15 (Modestly Overvalued). The stock has 2 warning signs investors should review.

PT Metro Healthcare Indonesia Tbk's Long-Term Debt for the quarter that ended in Mar. 2026 was Rp525,985 Mil.

PT Metro Healthcare Indonesia Tbk's quarterly Long-Term Debt declined from Sep. 2025 (Rp541,376 Mil) to Dec. 2025 (Rp530,474 Mil) and declined from Dec. 2025 (Rp530,474 Mil) to Mar. 2026 (Rp525,985 Mil).

PT Metro Healthcare Indonesia Tbk's annual Long-Term Debt declined from Dec. 2023 (Rp129,659 Mil) to Dec. 2024 (Rp122,235 Mil) but then increased from Dec. 2024 (Rp122,235 Mil) to Dec. 2025 (Rp530,474 Mil).


PT Metro Healthcare Indonesia Tbk  (ISX:CARE) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


PT Metro Healthcare Indonesia Tbk Long-Term Debt Related Terms


PT Metro Healthcare Indonesia Tbk Long-Term Debt Historical Data

* Premium members only.

The historical data trend for PT Metro Healthcare Indonesia Tbk's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Metro Healthcare Indonesia Tbk Long-Term Debt Chart

PT Metro Healthcare Indonesia Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 825,689.63 807,700.12 129,658.68 122,235.15 530,473.52

PT Metro Healthcare Indonesia Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 111,114.82 106,631.10 541,376.32 530,473.52 525,984.84
ISX:CARE
76GF Score
PT Metro Healthcare Indonesia Tbk ISX:CARE
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of Rp525,985 Mil mean?
PT Metro Healthcare Indonesia Tbk (ISX:CARE) has a Long-Term Debt of Rp525,985 Mil as of Mar. 2026.
Is PT Metro Healthcare Indonesia Tbk's Long-Term Debt too high?
PT Metro Healthcare Indonesia Tbk's current Long-Term Debt is Rp525,985 Mil. Overall, PT Metro Healthcare Indonesia Tbk has a GF Score™ of 76/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Metro Healthcare Indonesia Tbk's Long-Term Debt compare to HCA and THC?
PT Metro Healthcare Indonesia Tbk's Long-Term Debt of Rp525,985 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Healthcare Providers & Services company?
A good Long-Term Debt depends on the Healthcare Providers & Services industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. PT Metro Healthcare Indonesia Tbk's current Long-Term Debt is Rp525,985 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Metro Healthcare Indonesia Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Metro Healthcare Indonesia Tbk (ISX:CARE) is currently considered Modestly Overvalued. The stock's GF Value™ is Rp370.15, compared to a current price of Rp418.00 — trading 12.9% above its estimated fair value. The current Long-Term Debt is Rp525,985 Mil. PT Metro Healthcare Indonesia Tbk's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For PT Metro Healthcare Indonesia Tbk (ISX:CARE), the current Long-Term Debt is Rp525,985 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Metro Healthcare Indonesia Tbk (ISX:CARE) Overvalued in 2026?

Based on GuruFocus' analysis, PT Metro Healthcare Indonesia Tbk stock appears to be overvalued. The current stock price of Rp418.00 is trading 12.9% above its estimated GF Value™ of Rp370.15. GuruFocus considers PT Metro Healthcare Indonesia Tbk to be Modestly Overvalued.

Key valuation signals for ISX:CARE:

  • Long-Term Debt: Rp525,985 Mil
  • GF Value™: Rp370.15 vs. price of Rp418.00 (12.9% above fair value)
  • GF Score™: 76/100 with 2 warning signs

No single metric tells the full story. See the ISX:CARE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Metro Healthcare Indonesia Tbk Business Description

Address Jalan Raya Serang Km 16,8, RT / RW 005/001, Kel. Sukamulya, Kec. Cikupa, Tangerang, IDN, 15710
PT Metro Healthcare Indonesia Tbk provides integrated health services that consist of hospital and technology-based health services and training centers to produce professionals in health services. The company manages hospitals that are members of the Metro Hospital Group. Its business segment comprises Hospital services and Investment. The majority of revenue is derived from the Hospital services segment that comprises integrated healthcare services for inpatient and outpatient.
76GF Score

Get the complete analysis for ISX:CARE

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp418.00
Price
Rp370.15
GF Value